Research Analysts Set Expectations for Humana Q1 Earnings

Key Points

• Zacks Research raised Humana’s Q1 2027 EPS estimate to $9.13 from $9.04 and projects Q2 2027 EPS of $5.30. Zacks maintains a “Hold” rating.
• Analyst sentiment remains mixed but leans cautious, with a consensus “Hold” rating and an average price target of $408.61; Humana shares opened at $386.55.
• Humana’s latest quarterly results exceeded expectations, reporting $7.61 EPS and $40.89 billion in revenue, while quarterly revenue increased 26.2% year over year. The company also declared a quarterly dividend of $0.885 per share.

Humana Inc. (NYSE:HUM - Free Report) - Zacks Research raised their Q1 2027 earnings per share (EPS) estimates for Humana in a research note issued on Tuesday, September 29th. Zacks Research analyst Team now expects that the insurance provider will earn $9.13 per share for the quarter, up from their previous estimate of $9.04. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Humana's current full-year earnings is $9.00 per share. Zacks Research also issued estimates for Humana's Q2 2027 earnings at $5.30 EPS and Q2 2028 earnings at $6.69 EPS.

HUM has been the topic of several other research reports. Truist Financial boosted their target price on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a research note on Sunday. Wolfe Research restated an "outperform" rating and issued a $450.00 price objective on shares of Humana in a report on Monday, August 24th. Leerink Partners raised Humana from a "market perform" rating to an "outperform" rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. Finally, Piper Sandler upgraded shares of Humana from a "hold" rating to an "overweight" rating and set a $463.00 price objective for the company in a research report on Thursday, July 30th. Fifteen analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $408.61.

Humana Trading Down 0.8%

Shares of NYSE:HUM opened at $386.55 on Wednesday. The company has a 50 day moving average of $386.00 and a 200-day moving average of $321.83. The firm has a market cap of $46.42 billion, a P/E ratio of 36.57, a P/E/G ratio of 2.41 and a beta of 0.74. Humana has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company's quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.27 earnings per share.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a dividend of $0.8850 per share. The ex-dividend date is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. Humana's dividend payout ratio (DPR) is presently 33.49%.

Institutional Trading of Humana

A number of hedge funds have recently made changes to their positions in the stock. Johnson Financial Group Inc. purchased a new stake in Humana in the 2nd quarter worth approximately $26,000. Trust Co. of Vermont acquired a new stake in Humana during the second quarter valued at $28,000. Bogart Wealth LLC boosted its position in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. MidFirst Bank purchased a new position in Humana in the second quarter valued at about $35,000. Finally, Fideuram Asset Management Ireland dac purchased a new position in Humana in the fourth quarter valued at about $27,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana's insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.